COVID-19: Bahrain approves emergency use for regn-cov2 medicine
Report says updating treatment protocol would reduce symptoms, complications
Last updated:
1 MIN READ
Also In This Package
Cairo: Bahrain on Wednesday approved the emergency use for regn-cov2 medicine, Regeneron Pharmaceuticals Incs and Roche's newly authorised COVID-19 antibody combination, as part of its coronavirus treatment protocol to treat existing cases with mild and moderate symptoms, the state news agency (BNA) reported.
The report said updating the corona treatment protocol in the kingdom would reduce symptoms complications.
Related Topics:
Get Updates on Topics You Choose
Up Next
